Oslo, May 18, 2021
ODI Medical is proud to announce and welcome Yngve Mikkelsen as the Company’s Senior Medical Officer. “We are very excited to welcome Yngve to our team at ODI Medical,” said Stein Bleivik, CEO. “Not only will he bring a tighter focus on clinical development of our technology, but also be a great resource for our regulatory efforts.”
Dr. Mikkelsen brings with him twenty years of healthcare and industry management experience in addition to more than fifteen years of experience in clinical development from pharma, biotech and MedTech. He has worked as Medical Director/Team leader for Pfizer EUCANZ, medical director in Biogen, EVP/CMO Akershus university hospital, and EVP/CMO LINK Medical Research. Dr. Mikkelsen is also an objective world evidence (RWE) and health technology (HTA) expert with 20 RWE studies and 50 HTA submissions.
Dr. Mikkelsen is a medical doctor with a clinical specialty in anesthesiology and holds a Master of Management from the Norwegian Business School, a Master of Science in health economics, policy and management from the London School of Economics, and a Doctor of Business Administration from Cranfield University.
In his role, EVP and CMO of LINK Medical, before joining ODI Medical, Dr. Mikkelsen developed a professional service consulting service to include early development, HTA and RWE guiding industry in developing reimbursable technologies benefiting patients.